Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
Bipolar disorder (type 1) is a serious and chronic psychiatric illness that can be difficult to treat. Many bipolar patients have refractory depressive episodes. Racemic ketamine, a glutamate modulator with prominent dissociate and psychedelic properties, has been demonstrated to have rapid acting a...
Main Authors: | Raquel Bennett, Christian Yavorsky, Gary Bravo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.867484/full |
Similar Items
-
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
by: Nicolas Garel, et al.
Published: (2023-09-01) -
The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
by: Muhammad Youshay Jawad, et al.
Published: (2023-06-01) -
Editorial: The psychotherapeutic framing of psychedelic drug administration
by: Maria Beckman, et al.
Published: (2023-01-01) -
Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses
by: Philip E. Wolfson, et al.
Published: (2023-03-01) -
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach
by: Phil Wolfson, et al.
Published: (2024-02-01)